Effects of lansoprazole on human gastric lipase secretion and intragastriclipolysis in healthy human volunteers

Citation
C. Renou et al., Effects of lansoprazole on human gastric lipase secretion and intragastriclipolysis in healthy human volunteers, DIGESTION, 63(4), 2001, pp. 207-213
Citations number
17
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
DIGESTION
ISSN journal
00122823 → ACNP
Volume
63
Issue
4
Year of publication
2001
Pages
207 - 213
Database
ISI
SICI code
0012-2823(2001)63:4<207:EOLOHG>2.0.ZU;2-B
Abstract
Background: Lansoprazole is a potent proton-pump inhibitor (PPI) of parieta l cells, which reduces the secretion of gastric acid. Although human gastri c lipase (HGL) is produced only by the chief cells of the stomach, the poss ibility that interactions may occur between lansoprazole and HGL has never been addressed so far in humans. The aim of this study was therefore to qua ntify the effects of lansoprazole on HGL secretion and intragastric lipolys is during the ingestion of test meals by healthy human volunteers. Methods: Six healthy volunteers were intubated twice with a gastric and a duodenal tube, before ingesting a standard liquid test meal alone (-PPI experiments) and after 7 days of lansoprazole treatment (+PPI experiments). The HGL con centration was assessed in gastric and duodenal samples by measuring the li pase activity using a pH-stat, and the lipolysis products were quantified b y performing thin layer chromatography. The level of intragastric lipolysis was defined as the percentage acyl chains released from the meal triglycer ides. The pyloric outputs of HGL and lipolysis products were calculated, ba sed on the use of a nonabsorbable marker added to the meal. Results: The pH of the gastric contents was significantly higher in the +PPI experiments t han in the -PPI experiments (p < 0.05), since mean values of 4.3<plus/minus >2.5 and 2.2 +/-1.6, respectively, were recorded at the end of the gastric emptying of the meal. The HGL concentrations recorded during the meal were found to be higher in the experiments with lansoprazole (p < 0.05) than in those without lansoprazole, but the HGL secretion levels (-PPI: 15.4<plus/m inus>8.0mg; +PPI: 19.0 +/-7.4 mg) and the intragastric lipolysis (-PPI: 24. 0 +/-8.0%; +PPI: 23.6 +/-6.8%) were not significantly affected by lansopraz ole (p > 0.05 in both cases). Conclusion: Lansoprazole affected neither the HGL secretion nor the intragastric lipolysis levels, although an increase was observed in the intragastric pH at the end of the gastric emptying of t he meal. The HGL concentration increased, however, due to the decrease in t he acid secretion process, resulting in less diluted gastric contents. Copy right (C) 2001 S. Karger AG, Basel.